Literature DB >> 19856365

Inhibition of HSP90 with pochoximes: SAR and structure-based insights.

Sofia Barluenga1, Jean-Gonzague Fontaine, Cuihua Wang, Kais Aouadi, Ruihong Chen, Kristin Beebe, Len Neckers, Nicolas Winssinger.   

Abstract

The pochoximes, based on the radicicol pharmacophore, are potent inhibitors of heat shock protein 90 (HSP90) that retain their activity in vivo. Herein we report an extended library that broadly explores the structure-activity relationship (SAR) of the pochoximes with four points of diversity. Several modifications were identified that afford improved cellular efficacy, new opportunities for conjugation, and further diversifications. Cocrystal structures of pochoximes A and B with HSP90 show that pochoximes bind to a different conformation of HSP90 than radicicol and provide a rationale for the enhanced affinity of the pochoximes relative to radicicol and the pochonins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19856365      PMCID: PMC7556317          DOI: 10.1002/cbic.200900494

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  42 in total

1.  Modular synthesis of radicicol A and related resorcylic acid lactones, potent kinase inhibitors.

Authors:  Pierre-Yves Dakas; Sofia Barluenga; Frank Totzke; Ute Zirrgiebel; Nicolas Winssinger
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

2.  Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol.

Authors:  Nicolas Proisy; Swee Y Sharp; Kathy Boxall; Stephen Connelly; S Mark Roe; Chrisostomos Prodromou; Alexandra M Z Slawin; Laurence H Pearl; Paul Workman; Christopher J Moody
Journal:  Chem Biol       Date:  2006-11

Review 3.  Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.

Authors:  Gabriela Chiosis; Eloisi Caldas Lopes; David Solit
Journal:  Curr Opin Investig Drugs       Date:  2006-06

4.  Design, synthesis, and biological evaluation of HSP90 inhibitors based on conformational analysis of radicicol and its analogues.

Authors:  Emilie Moulin; Vincent Zoete; Sofia Barluenga; Martin Karplus; Nicolas Winssinger
Journal:  J Am Chem Soc       Date:  2005-05-18       Impact factor: 15.419

5.  Diversity-oriented synthesis of pochonins and biological evaluation against a panel of kinases.

Authors:  Emilie Moulin; Sofia Barluenga; Frank Totzke; Nicolas Winssinger
Journal:  Chemistry       Date:  2006-11-24       Impact factor: 5.236

Review 6.  Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update.

Authors:  Len Neckers; Katharine Neckers
Journal:  Expert Opin Emerg Drugs       Date:  2005-02       Impact factor: 4.191

7.  Discovery and development of purine-scaffold Hsp90 inhibitors.

Authors:  Gabriela Chiosis; Yanlong Kang; Weilin Sun
Journal:  Expert Opin Drug Discov       Date:  2008-01       Impact factor: 6.098

8.  SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers.

Authors:  Sarat Chandarlapaty; Ayana Sawai; Qing Ye; Anisa Scott; Melanie Silinski; Ken Huang; Pat Fadden; Jeff Partdrige; Steven Hall; Paul Steed; Larry Norton; Neal Rosen; David B Solit
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

9.  NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis.

Authors:  Suzanne A Eccles; Andy Massey; Florence I Raynaud; Swee Y Sharp; Gary Box; Melanie Valenti; Lisa Patterson; Alexis de Haven Brandon; Sharon Gowan; Frances Boxall; Wynne Aherne; Martin Rowlands; Angela Hayes; Vanessa Martins; Frederique Urban; Kathy Boxall; Chrisostomos Prodromou; Laurence Pearl; Karen James; Thomas P Matthews; Kwai-Ming Cheung; Andrew Kalusa; Keith Jones; Edward McDonald; Xavier Barril; Paul A Brough; Julie E Cansfield; Brian Dymock; Martin J Drysdale; Harry Finch; Rob Howes; Roderick E Hubbard; Alan Surgenor; Paul Webb; Mike Wood; Lisa Wright; Paul Workman
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

10.  Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents.

Authors:  Kenneth H Huang; James M Veal; R Patrick Fadden; John W Rice; Jeron Eaves; Jon-Paul Strachan; Amy F Barabasz; Briana E Foley; Thomas E Barta; Wei Ma; Melanie A Silinski; Mei Hu; Jeffrey M Partridge; Anisa Scott; Laura G DuBois; Tiffany Freed; Paul M Steed; Andy J Ommen; Emilie D Smith; Philip F Hughes; Angela R Woodward; Gunnar J Hanson; W Stephen McCall; Christopher J Markworth; Lindsay Hinkley; Matthew Jenks; Lifeng Geng; Meredith Lewis; James Otto; Bert Pronk; Katleen Verleysen; Steven E Hall
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

View more
  10 in total

1.  The novel Hsp90 inhibitor NXD30001 induces tumor regression in a genetically engineered mouse model of glioblastoma multiforme.

Authors:  Haihao Zhu; Steve Woolfenden; Roderick T Bronson; Zahara M Jaffer; Sofia Barluenga; Nicolas Winssinger; Allan E Rubenstein; Ruihong Chen; Al Charest
Journal:  Mol Cancer Ther       Date:  2010-07-19       Impact factor: 6.261

2.  Concise modular asymmetric synthesis of deguelin, tephrosin and investigation into their mode of action.

Authors:  José Garcia; Sofia Barluenga; Kristin Beebe; Len Neckers; Nicolas Winssinger
Journal:  Chemistry       Date:  2010-08-23       Impact factor: 5.236

3.  Insights into radicicol biosynthesis via heterologous synthesis of intermediates and analogs.

Authors:  Hui Zhou; Kangjian Qiao; Zhizeng Gao; John C Vederas; Yi Tang
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

4.  A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo.

Authors:  Jieun R C Cha; Kyle J H St Louis; Miranda L Tradewell; Benoit J Gentil; Sandra Minotti; Zahara M Jaffer; Ruihong Chen; Allan E Rubenstein; Heather D Durham
Journal:  Cell Stress Chaperones       Date:  2013-10-03       Impact factor: 3.667

5.  The molecular chaperone Hsp90α is required for meiotic progression of spermatocytes beyond pachytene in the mouse.

Authors:  Iwona Grad; Christopher R Cederroth; Joël Walicki; Corinne Grey; Sofia Barluenga; Nicolas Winssinger; Bernard De Massy; Serge Nef; Didier Picard
Journal:  PLoS One       Date:  2010-12-31       Impact factor: 3.240

6.  Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer.

Authors:  Liang Ma; Fuminori Sato; Ryuta Sato; Takanori Matsubara; Kenichi Hirai; Mutsushi Yamasaki; Toshitaka Shin; Tatsuo Shimada; Takeo Nomura; Kenichi Mori; Yasuhiro Sumino; Hiromitsu Mimata
Journal:  Oncol Rep       Date:  2014-04-09       Impact factor: 3.906

7.  Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond.

Authors:  Michael Orth; Valerie Albrecht; Karin Seidl; Linda Kinzel; Kristian Unger; Julia Hess; Lisa Kreutzer; Na Sun; Benjamin Stegen; Alexander Nieto; Jessica Maas; Nicolas Winssinger; Anna A Friedl; Axel K Walch; Claus Belka; Horst Zitzelsberger; Maximilian Niyazi; Kirsten Lauber
Journal:  Front Oncol       Date:  2021-03-17       Impact factor: 6.244

8.  Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design.

Authors:  Juan Carlos Pizarro; Tanya Hills; Guillermo Senisterra; Amy K Wernimont; Claire Mackenzie; Neil R Norcross; Michael A J Ferguson; Paul G Wyatt; Ian H Gilbert; Raymond Hui
Journal:  PLoS Negl Trop Dis       Date:  2013-10-17

9.  A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer.

Authors:  Linda Kinzel; Anne Ernst; Michael Orth; Valerie Albrecht; Roman Hennel; Nikko Brix; Benjamin Frey; Udo S Gaipl; Gabriele Zuchtriegel; Christoph A Reichel; Andreas Blutke; Daniela Schilling; Gabriele Multhoff; Minglun Li; Maximilian Niyazi; Anna A Friedl; Nicolas Winssinger; Claus Belka; Kirsten Lauber
Journal:  Oncotarget       Date:  2016-07-12

10.  A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer's mouse model via an HSF1-mediated mechanism.

Authors:  B Wang; Y Liu; L Huang; J Chen; J J Li; R Wang; E Kim; Y Chen; C Justicia; K Sakata; H Chen; A Planas; R S Ostrom; W Li; G Yang; M P McDonald; R Chen; D H Heck; F-F Liao
Journal:  Mol Psychiatry       Date:  2016-07-26       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.